Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Dose, Open Label, Randomized, Two-period Cross Over Study in Healthy Male Subjects to Assess the Absolute Bioavailability of YM178 OCAS-M Formulation

NCT01478529 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT01478529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01478529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Dose, Open Label, Randomized, Two-period Cross Over Study in Healthy Male Subjects to Assess the Absolute Bioavailability of YM178 OCAS-M Formulation
Lead sponsor
Astellas Pharma Inc
Phase
Phase 1
Overall status
Completed
Start date
February 28, 2006
Completion date
March 31, 2006
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bioavailability, healthy subjects, pharmacokinetics of mirabegron